Recovery of Nail Dystrophy: Potential New Therapeutic Indication of Tofacitinib
February 2017
in “
Clinical rheumatology
”
TLDR Tofacitinib may help treat nail dystrophy, especially when other treatments fail.
The document reported that tofacitinib, a therapy initially developed for rheumatoid arthritis, showed potential benefits for patients with nail dystrophy, particularly those whose condition was resistant to conventional treatments. This finding suggested a new therapeutic indication for tofacitinib in treating nail diseases associated with autoimmune conditions like psoriasis and psoriatic arthritis.